APOE and Alzheimer disease: EVs were shown to reduce neural degeneration in cells treated with conditioned media of brain organoids derived from iPSCs of a sporadic AD patient with an APOE ε4/ε4 mutation that models neural degeneration in Alzheimer’s disease.